How purity affects the performance of fungicide technical material

Purity in fungicide technical material is not a cosmetic specification. It defines how much of the declared active substance is actually available for formulation, but its more consequential role is controlling the chemical entities that accompany that active substance. Those entities can change solubility, particle formation, emulsion behavior, storage stability, toxicological interpretation, crop safety, and the consistency of the product placed on the market.

A high assay result therefore answers only part of the quality question. A technical material can meet its nominal active-ingredient content and still create formulation or registration problems if its impurity profile is poorly characterized, variable between batches, or incompatible with the intended formulation route. The relevant assessment is not “how pure is it?” in isolation, but whether the assay, impurity pattern, physical properties, and manufacturing origin are controlled tightly enough to support a defined formulated product and its approved use pattern.

Purity is a composition profile, not just an assay number

Fungicide technical material, often described in specifications as technical active ingredient or technical grade active ingredient, is the material produced after synthesis and purification but before formulation into products such as suspension concentrates (SC), emulsifiable concentrates (EC), wettable powders (WP), water-dispersible granules (WG), or soluble concentrates (SL).

Its reported purity is commonly the mass fraction of the intended active ingredient, determined by a validated analytical method such as HPLC, GC, titration, or another substance-appropriate technique. This figure matters because formulated-product dosage, label claim, and batch calculations depend on it. Yet the remainder is not a chemically neutral “balance.” It may include:

• unreacted starting materials and intermediates;
• isomers, stereoisomers, homologues, or positional by-products;
• overreaction products and degradation products;
• residual catalysts, inorganic salts, acids, or bases;
• residual process solvents and water;
• materials introduced through work-up, drying, milling, or packaging.

Different impurities do not carry the same technical significance. A small amount of a chemically similar, non-reactive isomer may have limited effect on a robust EC formulation. A trace level of a strongly colored oxidation product, reactive chlorinated intermediate, metal residue, or acidic component may be far more important, even where the total assay appears high. This is why a technical specification should distinguish the active-ingredient minimum from limits for relevant impurities and from physical-quality parameters.

The direct effect on biological performance

The nominal concentration of active ingredient in a formulated fungicide is calculated from the technical assay. If technical material has lower active content than assumed, and formulation calculations are not corrected, the final product can be under-strength. This produces a straightforward efficacy risk: the applied dose per hectare falls below the intended dose, which can reduce disease control and complicate interpretation of field performance.

The more difficult issue is that impurities may alter efficacy without substantially changing the declared active content. Some synthesis-related compounds can compete for formulation components, affect droplet spreading, or modify the release of active ingredient from a dry formulation. In contact fungicides, where surface coverage and retention are central to performance, changes in particle size, wetting, and deposition can be as important as the active assay. In systemic fungicides, impurities that alter solubility, crystallization, or the condition of the spray deposit may influence uptake and redistribution in plant tissue.

These effects should not be assumed from chemical structure alone. The appropriate question is whether the impurity profile changes a property linked to the use mechanism: dissolution rate, dispersion quality, emulsion stability, particle-size distribution, surface tension, deposit morphology, or chemical stability after dilution. A biological difference is most likely to emerge when the active substance has low water solubility, narrow formulation tolerance, polymorphic behavior, or sensitivity to hydrolysis or oxidation.

Purity also affects the reliability of comparative trials. When technical batches with different impurity profiles are used to prepare apparently identical formulations, a change in disease-control result may be incorrectly attributed to the active ingredient, adjuvant package, or application conditions. Without batch-level composition data, formulation-development and efficacy data can become difficult to interpret.

Why the “missing percentage” can destabilize a formulation

Formulation performance is governed by interactions among active particles or dissolved active ingredient, solvents, surfactants, dispersants, water, and other functional ingredients. Impurities can disrupt these interactions even at levels too low to materially affect the active assay.

In an EC, residual polar compounds or water can reduce the solvent system’s capacity to keep the active ingredient dissolved. A concentrate that is clear at release may crystallize during cold storage, form haze, or fail dilution-emulsion testing after transport. Conversely, an impurity with surfactant-like behavior can modify emulsification unexpectedly, producing an unstable emulsion or a changed droplet-size profile after dilution.

For SC and WG products, the technical material’s crystal habit and surface chemistry matter. A batch that contains a different proportion of related compounds may mill differently, consume more dispersant, or generate a broader particle-size distribution. The immediate result may be higher viscosity or lower suspensibility; the delayed result can be sediment compaction, crystal growth during storage, or nozzle blockage in use. High active assay does not guarantee acceptable behavior if the solid-state characteristics have changed.

Water is particularly important because many fungicide active ingredients or process residues are susceptible to hydrolysis. Moisture can also promote caking in powders and granules, change flow behavior, or accelerate interactions between technical material and formulation additives. A water specification should be selected according to the active substance and formulation route rather than treated as a generic dryness target.

Acidity and alkalinity require similar attention. Trace acid or base residues can catalyze active-ingredient degradation, alter dispersant ionization, corrode processing equipment, or change the pH of spray dilution. A specification for pH is meaningful only when the measurement medium, concentration, temperature, and test method are defined. For non-aqueous technical materials, acidity or alkalinity expressed through an appropriate chemical test may be more informative than an arbitrary pH value.

Impurities can create crop-safety risks that assay testing will not reveal

Phytotoxicity is often discussed as a consequence of overdose, tank-mix incompatibility, environmental stress, or inappropriate application timing. Technical-material quality can be an additional source. A minor impurity may be more soluble, more mobile, or more biologically active on crop tissue than the parent fungicide. Residual solvents or reactive intermediates can also damage leaf cuticles, intensify uptake, or interact adversely with co-formulants.

The risk is not uniform across crop systems. A material tolerated in a broad-acre cereal application may be unsuitable for a high-value horticultural crop, seedlings, protected cultivation, or varieties known to have narrow crop-safety margins. Formulation concentration also matters: impurities that are insignificant at a low use concentration can become relevant in high-load concentrates, seed treatment systems, or localized applications.

Analytical control is therefore not limited to checking that “unknown impurities” remain low. Impurities need to be assessed for identity, concentration, persistence, and plausible relevance to toxicology, ecotoxicology, residue behavior, or plant response. Where a relevant impurity has been identified, it should be controlled with a specific limit and a method capable of distinguishing it from the active substance and other components.

Manufacturing route changes the meaning of a purity claim

Two fungicide technical materials with the same active assay are not automatically interchangeable. A change in synthesis route, starting material, catalyst, solvent, purification sequence, crystallization solvent, or drying process can produce a different impurity spectrum. For chiral fungicides, the ratio of stereoisomers can be especially important where biological activity or toxicological properties differ between isomers. For substances with multiple crystalline forms, a process change can also affect polymorph composition and downstream handling.

This distinction is central to source qualification. A certificate of analysis that states the active content alone cannot establish technical equivalence. The certificate should be considered alongside the manufacturing source, declared specification, chromatographic impurity profile, residual-solvent data where relevant, moisture or volatile content, and physical-form information. Batch consistency is as important as one compliant batch.

A change-control system should require advance notification and technical review when a supplier changes manufacturing site, reaction route, key raw-material source, purification method, or product specification. Even a change presented as a yield or cost improvement can alter impurities that were absent from the original regulatory and formulation evaluation. Requalification may require more than a repeat assay; it can require confirmatory formulation work and assessment against the applicable registration dossier.

Purity and regulatory consistency are linked, but they are not identical

Regulatory evaluation of pesticide active substances generally considers the identity and composition of the technical material, including impurities that are toxicologically or environmentally relevant. Requirements differ by jurisdiction and product category, but the underlying principle is consistent: the material used in commerce should correspond to the identity and composition that support the safety assessment.

FAO and WHO pesticide specifications provide an internationally recognized framework for defining quality requirements for certain pesticide technical materials and formulations. Their manuals address matters such as active-ingredient content, relevant impurities, physical properties, sampling, and test methods. A published FAO/WHO specification, however, is substance-specific and should not be treated as a universal substitute for national registration requirements, a product registration dossier, or a customer’s agreed technical specification.

In many regulated markets, a new impurity, a higher level of an existing relevant impurity, or a material produced by a materially different process can trigger additional regulatory scrutiny. The technical concern is not simply formal compliance. Safety studies, residue studies, and efficacy studies may have been generated using a technical material of defined composition. If commercial material differs materially from that composition, the evidence base may no longer map cleanly onto the product being supplied.

This is why “higher purity” is not always sufficient language in a regulatory discussion. A higher assay may reduce total unidentified content, but it does not by itself demonstrate that all relevant impurities are controlled or that the source is equivalent to the assessed material. Identity, impurity qualification, and manufacturing consistency remain separate questions.

Setting a defensible specification

A workable specification starts with the intended use of the technical material. The same active substance may require different control emphasis depending on whether it will be processed into an EC, SC, WG, seed treatment, or another delivery system. It should also reflect the impurity profile of the established manufacturing process rather than an aspirational assay figure detached from production reality.

The most useful specification normally contains four layers of control:

• Active ingredient: a defined minimum content measured by a validated, fit-for-purpose assay method.
• Relevant impurities: named limits for substances that have toxicological, ecotoxicological, residue, crop-safety, formulation, or regulatory significance.
• General composition indicators: limits for water, volatile matter, insoluble matter, residual solvents, acidity/alkalinity, ash, or metals where these properties can affect the material.
• Physical identity and handling properties: appearance, color where meaningful, melting range or other identity markers, particle characteristics, density, and flow-related properties as needed for the formulation process.

The analytical method is part of the specification, not an administrative attachment. Methods must have adequate selectivity for impurities close to the active peak, defined calibration practice, acceptable precision, and an appropriate limit of quantification. A total “other impurities” result may conceal a shift in one critical impurity if the method is not sufficiently resolved. For low-level genotoxic or otherwise highly relevant impurities, the analytical control strategy may need a more sensitive and specific method than the routine assay method.

Sampling deserves equal attention. Technical materials can segregate during storage and transport, particularly where particle size varies or where moisture distribution is uneven. A representative sample should reflect the lot, container configuration, and physical state of the material. Results from a single convenient surface sample provide weak assurance for a bulk shipment.

How to interpret supplier documentation without over-reading it

A certificate of analysis is a release document, not a complete technical evaluation. It is strongest when it identifies the batch, production date, test methods, specification limits, actual results, and authorized release status. It is less informative when it reports only an assay value and generic statements such as “conforms.”

For a fungicide technical material under evaluation, the central comparison is between the supplier’s routine release specification and the composition required by the intended formulation and regulatory position. Questions that materially affect the decision include whether identified impurities are routinely reported, whether limits are based on validated methods, whether the impurity profile is stable across representative batches, and whether any result is reported as “not detected” without stating the method’s detection capability.

Retained-sample testing can be valuable when a batch is used for formulation development, stability studies, or regulatory-support work. It enables later investigation if the formulated product shows crystallization, viscosity drift, unexpected discoloration, reduced suspensibility, or a change in biological response. Without traceability from formulated batch back to technical-material lot, root-cause analysis becomes substantially weaker.

Higher purity is valuable only when it controls the right variables

A purity target should not be selected as a simple “highest number wins” criterion. Excessively narrow limits can exclude otherwise suitable material without improving formulation or use performance. More importantly, a high assay can create false confidence if relevant impurities, water, residual solvents, isomer ratios, or physical-form attributes remain uncontrolled.

The sound technical position is to define quality in terms of fitness for a specific fungicide product: correct active concentration, known and controlled impurity profile, reproducible physical behavior, compatibility with the formulation system, and consistency with the composition that supports regulatory approval. Purity is the entry point to that assessment, but it is never the whole assessment.